Content about Sanofi-Aventis

May 18, 2012
Dr. Reddy's launches generic version of Plavix

Generic drug maker Dr. Reddy's Labs has launched a generic version of a drug used to prevent clotting of the blood.

May 17, 2012
FDA approves generic versions of Plavix

The Food and Drug Administration has approved generic versions of one of the country's top-selling drugs made by eight different companies, the agency said Thursday.

May 16, 2012
Generic Plavix arrives at Walmart, Sam's Club stores

Walmart and Sam's Club will be among the first retailers to offer a generic version of an antiplatelet drug.

April 2, 2012
Teva launches generic hypertension drugs

Teva Pharmaceutical Industries has launched generic versions of two blood pressure drugs made by Sanofi, Teva said Monday.

March 9, 2012
Kerr Drug, UNC pharmacy school to collaborate in pharmacogenetic study

A regional retail pharmacy chain and a nearby school of pharmacy will collaborate on a study to evaluate the implementation of a pharmacogenetic program in a community pharmacy setting.

February 8, 2012
FDA approves Sanofi lice treatment

The Food and Drug Administration has approved a head lice treatment made by Sanofi, the drug maker said.

January 26, 2012
Federal court clears way for Watson, Amphastar to launch generic version of Lovenox

A federal court has stopped an injunction that would have prevented drug maker Watson Pharmaceuticals and partner company Amphastar Pharmaceuticals from marketing or selling a generic version of a blood-thinning drug.

November 23, 2011
FDA approves first drug for insomnia with middle-of-night waking, difficulty returning to sleep

The Food and Drug Administration has approved the first drug for insomnia in which patients wake in the middle of the night and have trouble returning to sleep.

November 14, 2011
Study: Pfizer, Bristol-Myers Squibb drug for internal blood clots not superior to enoxaparin

A drug under development by Pfizer and Bristol-Myers Squibb for preventing internal blood clots failed to show superiority over a treatment already on the market, the companies said Monday.

November 1, 2011
Pfizer could lose No. 1 global sales ranking to Sanofi next year, report finds

Pfizer soon may lose its distinction of having the highest global sales of any drug company, according to life sciences industry analysis firm EvaluatePharma.

October 31, 2011
Court injunction stops Watson, Amphastar from marketing, selling Lovenox generic

Watson Pharmaceuticals and a partnering company are barred from launching a generic version of a blood-thinning drug under a federal court decision issued Friday.

October 25, 2011
Sanofi appoints David Meeker as CEO of Genzyme

Sanofi has appointed David Meeker as CEO of Genzyme, the French drug maker said.

October 20, 2011
Byetta approved for use with Lantus

A diabetes drug made by Eli Lilly and Amylin Pharmaceuticals has received approval from the Food and Drug Administration for use with an insulin product made by Sanofi.

October 18, 2011
HDMA names six new directors; ABC's Neu appointed vice chair

The Healthcare Distribution Management Association on Tuesday named six new members to its board of directors.

October 11, 2011
Inspiration Biopharmaceuticals appoints former Genzyme exec as CEO

A drug maker that focuses on treatments for hemophilia has named a new CEO.

October 6, 2011
Sanofi MS drug shows good results in phase-3 trial

A drug under investigation by Sanofi for multiple sclerosis improved several measures of disease activity in patients, according to results of a late-stage clinical trial.

September 28, 2011
Sanofi supports flu shot awareness program targeting seniors

Sanofi Pasteur on Wednesday launched an awareness campaign to inform Florida residents ages 65 years and older about the importance of influenza protection and the key role vaccination plays in helping to improve the body's immune response against the virus.

September 23, 2011
Take Care Health Systems opens on-site medical center, pharmacy at Sanofi U.S. HQ

Take Care Health Systems, which is owned by Walgreens, and Sanofi U.S. have announced the opening of a full-service medical center and on-site pharmacy at Sanofi’s U.S. headquarters in Bridgewater, N.J.

August 30, 2011
Federal court issues rulings in favor of Teva in MS drug case

A federal court has acted in favor of Teva Pharmaceutical Industries in the drug maker's patent infringement case against several generic drug companies seeking to market versions of its multiple sclerosis drug.

August 23, 2011
Sandoz announces FDA approval, U.S. launch of chemotherapy drug

The Food and Drug Administration has approved a chemotherapy drug made by Sandoz, the drug maker said Tuesday.

August 12, 2011
Mylan ships generic prostate drug

Generic drug maker Mylan has begun shipping a drug for enlarged prostate, the company said Friday.

August 10, 2011
Sanofi launches Facebook contest promoting Allegra

Sanofi on Wednesday announced the introduction of Allegra's new Allergy Adventures contest on Facebook. Allergy sufferers are invited to upload a short video showing their daily challenges with allergies for a chance to win $5,000 toward a vacation package.

August 4, 2011
NASN, Sanofi Pasteur team up to raise awareness of meningitis

Meningococcal meningitis is rare but can kill preteens and teenagers in as little as a day. Yet many kids still engage in behaviors that put them at risk of contracting the disease despite not being vaccinated.

July 28, 2011
Sanofi announces executive changes

The president and CEO of Sanofi's U.S. operations is stepping into a newly created role at the drug maker.

July 21, 2011
Brilinta receives FDA approval

The Food and Drug Administration has approved a drug made by AstraZeneca to reduce the rate of heart attacks in patients with acute coronary syndrome, the Anglo-Swedish drug maker said.

© 2012 Drug Store News. All Rights Reserved.